Derek Hicks Sells $114K of Intellia Therapeutics Inc (NTLA) — SEC Form 4, Jan 05, 2024
Open-Market Net Sale · SEC Form 4
−$114,216
Equity position changed by -9.5%
Equity Position
37K sh
40,864 → 36,987
Equity Change
-9.5%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Derek Hicks CIK 0001901282 |
EVP
|
Derek Hicks at Intellia Therapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Intellia Therapeutics Inc
| 2025-01-07 | Sell | -$79,194 | View |
| 2024-03-05 | Award | — | View |
| 2023-03-03 | Award | — | View |
| 2023-01-06 | Sell | -$67,425 | View |
| 2022-01-05 | Award | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2024-01-03 | S - Sale | 3,877 D | $29.46 | -$114,216 | 36,987 | Direct |
Footnotes (1)
- F1
- Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1 and January 3, 2024, and does not represent a volitional trade by the Reporting Person. Show more
Related filings at Intellia Therapeutics Inc
Institutional Holders
13F holders · Jun 30, 2026
328
institutional managers reporting a position
Largest by reported value
- Ark Investment Management Llc $286M
- Black Rock, Inc. $261M
- State Street Corporation $156M
5%+ Holders · 13D/G
5 filers
Other insiders at Intellia Therapeutics Inc
-
John M Leonard -$108K
-
Michael P Dube -$23.2K
-
John M Leonard -$287K
-
Edward J Dulac III -$91.2K
GET /v1/forms/4/0000950170-24-002507
API docs
View Original SEC Filing